Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers-Reference-Cited by-同舟云学术

Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers

Published:2020-08 Issue: Volume:52 Page:17-22
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Yi Zongbi,Liu Binliang,Sun Xiaoying,Rong Guohua,Wang Wenna,Li Hui,Guan Xiuwen,Li Lixi,Zhai Jingtong,Li Chunxiao,Qian Haili,Ma Fei,Xu Binghe

Funder

CAMS

Beijing Municipal Science and Technology Commission

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference22 articles.

1. The association between type of endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: a systematic review and meta-analysis of randomized and non-randomized trials;Najim;Biochim Biophys Acta Rev Canc,2019

2. Breast cancer;Harbeck;Lancet,2017

3. The evolving role of the estrogen receptor mutations in endocrine therapy-resistant breast cancer;Jeselsohn;Curr Oncol Rep,2017

4. Clinical development of mTOR inhibitors in breast cancer;Vicier;Breast Cancer Res,2014

5. Targeting the PI3K/AKT/mTOR pathway: biomarkers of success and tribulation;Owonikoko;Am Soc Clin Oncol Educ Book,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Tumor DNA and Survival in Metastatic Breast Cancer;JAMA Network Open;2024-09-05

2. Obesity-Associated Colorectal Cancer;International Journal of Molecular Sciences;2024-08-14

3. Drug repositioning for immunotherapy in breast cancer using single-cell analysis;npj Systems Biology and Applications;2024-04-08

4. Guidelines for diagnosis and treatment of advanced breast cancer in China (2022 edition)✰;Journal of the National Cancer Center;2023-12

5. PROS1, a clinical prognostic biomarker and tumor suppressor, is associated with immune cell infiltration in breast cancer: A bioinformatics analysis combined with experimental verification;Cellular Signalling;2023-12